May 4, 2018 / 12:30 PM / 2 months ago

BRIEF-FDA Grants PaxVax Fast Track Designation For Its Chikungunya Vaccine

May 4 (Reuters) - PaxVax:

* FDA GRANTS PAXVAX FAST TRACK DESIGNATION FOR ITS CHIKUNGUNYA VACCINE

* PAXVAX SAYS HAS RECEIVED FAST TRACK DESIGNATION FROM U.S. FDA FOR ITS VACCINE FOR PREVENTION OF DISEASE CAUSED BY CHIKUNGUNYA VIRUS

* PAXVAX SAYS EXPECTS RESULTS FROM ITS PHASE 2B DOSE-FINDING TRIAL OF CHIKUNGUNYA VLP VACCINE IN EARLY 2019 Source text for Eikon:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below